Genetic counselling in ALS: Facts, uncertainties and clinical suggestions

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 85, Issue 5, 2014, Pages 478-485

  Chiò, Adriano ^a   Battistini, Stefania ^b   Calvo, Andrea ^a   Caponnetto, Claudia ^c   Conforti, Francesca L ^d   Corbo, Massimo ^e   Giannini, Fabio ^b   Mandrioli, Jessica ^f   Mora, Gabriele ^g   Sabatelli, Mario ^h   Ajmone, Clara ^e   Mastro, Enza ^a   Pain, Debora ^g   Mandich, Paola ^c   Penco, Silvana ⁱ   Restagno, Gabriella ^j   Zollino, Marcella ^h   Surbone, Antonella ^k   Monsurrò, Maria Rosaria ^l   Tedeschi, Gioacchino ^l   Conte, Amelia ^l   Luigetti, Marco ^l   Lattante, Serena ^l   Marangi, Giuseppe ^l   Volanti, Paolo ^m   Marinou, Kalliopi ^l   Papetti, Laura ^l   Lunetta, Christian ^l   Pintor, Giuseppe Lauria ^l   Salvi, Fabrizio ^l   Bartolomei, Ilaria ^l   Quattrone, Aldo ^l   Gambardella, Antonio ^l   Logroscino, Giancarlo ^l   Simone, Isabella ^l   Pisano, Fabrizio ^l   Spataro, Rossella ^l   La Bella, Vincenzo ^l   Colletti, Tiziana ^l   Mancardi, Gianluigi ^l   Origone, Paola ^l   Sola, Patrizia ^l   Borghero, Giuseppe ^l   Marrosu, Francesco ^l   Marrosu, Maria Giovanna ^l   Murru, Maria Rita ^l   Floris, Gianluca ^l   Cannas, Antonino ^l   Piras, Valeria ^l   Costantino, Emanuela ^l   Pani, Carla ^l   Sotgiu, Maria Alessandra ^l   Pugliatti, Maura ^l   Parish, Leslie D ^l   Cossu, Paola ^l   Ticca, Anna ^l   Rodolico, Carmelo ^l   Portaro, Simona ^l   Ricci, Claudia ^l   Moglia, Cristina ^l   Ossola, Irene ^l   Brunetti, Maura ^l   Barberis, Marco ^l   Canosa, Antonio ^l   Cammarosano, Stefania ^l   Bertuzzo, Davide ^l   Fuda, Giuseppe ^l   Ilardi, Antonio ^l   Manera, Umberto ^l   Pastore, Ilaria ^l   Sproviero, William ^l   Logullo, Francesco ^l   Tanel, Raffaella ^l   more..

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^e DEPARTMENT OF NEUROREHABILITATION SCIENCES   (Italy)

^f UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^g IRCCS   (Italy)

^h CATHOLIC UNIVERSITY   (Italy)

ⁱ OSPEDALE NIGUARDA CA GRANDA   (Italy)

^j Azienda Ospedaliera Città della Salute e della Scienza   (Italy)

^k NEW YORK UNIVERSITY   (United States)

^l NONE   (Italy)

^m NONE   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; FUSED IN SARCOMA PROTEIN;

AGE; AMYOTROPHIC LATERAL SCLEROSIS; C9ORF72 GENE; COMORBIDITY; CONFIDENTIALITY; DISEASE ASSOCIATION; FRONTOTEMPORAL DEMENTIA; FUS GENE; GENE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INFORMED CONSENT; MISSENSE MUTATION; NONSENSE MUTATION; PENETRANCE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SOD1 GENE; TARDBP GENE;

ALS; GENETICS;

AMYOTROPHIC LATERAL SCLEROSIS; FRONTOTEMPORAL DEMENTIA; GENETIC COUNSELING; GENETIC TESTING; GENOTYPE; HUMANS; MUTATION; PHENOTYPE;

EID: 84898847400     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2013-305546     Document Type: Review

References (59)

1. Miller TM, Pestronk A, David W, et al. An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study. Lancet Neurol 2013;12:435-42.
2. Andersen PM, Abrahams S, Borasio GD, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)- revised report of an EFNS task force. Eur J Neurol 2012;19:360-75.
3. Byrne S, Bede P, Elamin M, et al. Proposed criteria for familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2011;12:157-9.
4. Chiò A, Calvo A, Mazzini L, et al. Extensive genetics of ALS: a population-based study in Italy. Neurology 2012;79:1983-9.
5. Byrne S, Elamin M, Bede P, et al. Absence of consensus in diagnostic criteria for familial neurodegenerative diseases. J Neurol Neurosurg Psychiatry 2012;83:365-7.
6. Fanos JH, Gronka S, Wuu J, et al. Impact of asymptomatic at risk genetic testing for familial amyotrophic lateral sclerosis. Genet Med 2011;13:342-8.
7. Brooks BR, Miller RG, Swash M, et al. World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-9.
8. Chiò A, Traynor BJ. Identifying potential risk factors for developing amyotrophic lateral sclerosis. Neurodegen Dis Manage 2011;1:463-71.
9. Millecamps S, Boillée S, Le Ber I, et al. Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes. J Med Genet 2012;49:258-63.
10. Andersen PM. Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene. Curr Neurol Neurosci Rep 2006;6:37-46. (Pubitemid 43154251)
11. Van Es MA, Dahlberg C, Birve A, et al. Large-scale SOD1 mutation screening provides evidence for genetic heterogeneity in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2010;81:562-6.
12. Majounie E, Renton AE, Mok K, et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol 2012;11:323-30.
13. Tsai CP, Soong BW, Tu PH, et al. A hexanucleotide repeat expansion in C9ORF72 causes familial and sporadic ALS in Taiwan. Neurobiol Aging 2012;33:2232. e11-e18.
14. Ogaki K, Li Y, Atsuta N, et al. Analysis of C9orf72 repeat expansion in 563 Japanese patients with amyotrophic lateral sclerosis. Neurobiol Aging 2012;33:2527. e11-e6.
15. Felbecker A, Camu W, Valdmanis PN, et al. Four familial ALS pedigrees discordant for two SOD1 mutations: are all SOD1 mutations pathogenic? J Neurol Neurosurg Psychiatry 2010;81:572-7.
16. De Jesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region ofC9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011;72:245-56.
17. Fong JC, Karydas AM, Goldman JS. Genetic counseling for FTD/ALS caused by the C9ORF72 hexanucleotide expansion. Alzheimers Res Ther 2012;4:27.
18. Van Blitterswijk M, van Es MA, Hennekam EA, et al. Evidence for an oligogenic basis of amyotrophic lateral sclerosis. Hum Mol Genet 2012;21:3776-84.
19. Lattante S, Conte A, Zollino M, et al. Classification of familial amyotrophic lateral sclerosis by family history: effects on frequency of genes mutation. Neurology 2012;79:66-72.
20. Chiò A, Restagno G, Brunetti M, et al. ALS/FTD phenotype in two Sardinian families carrying both C9ORF72 and TARDBP mutations. J Neurol Neurosurg Psychiatry 2012;83:730-3.
21. Weishaupt JH, Waibel S, Birve A, et al. A novel optineurin truncating mutation and three glaucoma-associated missense variants in patients with familial amyotrophic lateral sclerosis in Germany. Neurobiol Aging 2013;34:1516. e9-15.
22. Andersen PM, Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol 2011;7:603-15.
23. Al-Chalabi A, Lewis CM. Modelling the effects of penetrance and family size on rates of sporadic and familial disease. Hum Hered 2011;71:281-8.
24. Hanby MF, Scott KM, Scotton W, et al. The risk to relatives of patients with sporadic amyotrophic lateral sclerosis. Brain 2011;134:3454-7.
25. Al-Chalabi A, Fang F, Hanby MF, et al. An estimate of amyotrophic lateral sclerosis heritability using twin data. J Neurol Neurosurg Psychiatry 2010;81:1324-6.
26. Alexander MD, Traynor BJ, Miller N, et al. "True" sporadic ALS associated with a novel SOD-1 mutation. Ann Neurol 2002;52:680-3. (Pubitemid 35246878)
27. Chiò A, Calvo A, Moglia C, et al. A de novo missense mutation of the FUS gene in a "true" sporadic ALS case. Neurobiol Aging 2011;32:553, e23-e26.
28. Praline J, Guennoc AM, Vourc'h P, et al. Primary lateral sclerosis may occur within familial amyotrophic lateral sclerosis pedigrees. Amyotroph Lateral Scler 2010;11:154-6.
29. Van Blitterswijk M, Vlam L, van Es MA, et al. Genetic Overlap between Apparently Sporadic Motor Neuron Diseases. PLoS One 2012;7:e48983.
30. Rahman B, Meiser B, Sachdev P, et al. To know or not to know: an update of the literature on the psychological and behavioral impact of genetic testing for Alzheimer disease risk. Genet Test Mol Biomarkers 2012;16:935-42.
31. Botkin JR, Croyle RT, Smith KR, et al. A model protocol for evaluating the behavior and psychosocial effects of BRCA1 testing. J Natl Cancer Inst 1996;88:872-81.
32. D'Agincourt-Canning L, Baird P. Genetic testing for hereditary cancers: the impact of gender on interest, uptake and ethical considerations. Crit Rev Oncol Hematol 2006;58:114-23.
33. American Society of Clinical Oncology Policy Statement Update. Genetic and genomic testing for cancer susceptibility. J Clin Oncol 2010;28:893-901.
34. Offitt K, Groeger E, Turner S. The "duty to warn" a patient's family members about hereditary disease risks. JAMA 2004;292:1469-73. (Pubitemid 39258340)
35. Lucassen A, Parker M. Confidentiality and sharing genetic information with relatives. Lancet 2010;375:1508-9.
36. Gilbar R. Communicating genetic information in the family: the familial relationship as the forgotten factor. J Med Ethics 2007;33:390-3.
37. McCluskey L. Asymptomatic at risk Genetic Testing for ALS. Virtual Mentor. Ethics J of Am Med Ass 2006;8:16-9.
38. Surbone A. Social and ethical implications of BRCA testing. Ann Oncol 2011;22 (suppl 1):i60-6.
39. Lolkema MP, Gadellaa-van Hooijdonk CG, Bredenoord Al, et al. Ethical, Legal, and Counseling Challenges Surrounding the Return of Genetic Results in Oncology. J Clin Oncol 2013;31:1842-8.
40. Billings PR, Kohn MA, deCuevas M, et al. Discrimination as a consequence of genetic testing. Am J Hum Genet 1992;40:476-82.
41. Matloff ET, Shappell H, Brierley K, et al. What would you do? Specialists' perspectives on cancer genetic testing, prophylactic surgery, and insurance discrimination. J Clin Oncol 2000;18:2484-92. (Pubitemid 30415836)
42. Billings PR. Genetic nondiscrimination. Nat Genet 2005;37:559-60. (Pubitemid 40770405)
43. Bill HR. 493 at http://thomas.loc.gov
44. Nicolas P. Ethical and juridical issues of genetic testing. A review of the international regulation. Crit Rev Oncol Hematol 2009;69:98-107.
45. Burke W, Pinsky LE, Press NA. Categorizing genetic tests to identify their ethical, legal, and social implications. Am J Med Genet 2001;106:233-40. (Pubitemid 32983391)
46. Rhodes R. Genetic links, family ties, and social bonds: rights and responsibilities in the face of genetic knowledge. J Med Phil 1988;23:10-30.
47. Shaw MW. Testing for Huntington gene: a right to know, a right not to know, or a duty to know. Am J Med Genet 1987;26:243-6.
48. Zinberg RE. Genetic testing: is there a right not to know? MCN Am J Matern Child Nurs 2006;31:144.
49. American College of Medical Genetics and Genomics. ACMG Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing. Approved March 19, 2013. http://www.acmg.net/AM/Template.cfm?Section=Home3 and http://www.acmg.net/docs/ACMGReleasesHighly-Anticipated RecommendationsonIncidentalFindingsinClinicalExomeandGenome Sequencing.pdf (accessed 31 May 2013).
50. Rodriguez LL, Brooks LD, Greenberg JH, et al. The Complexities of Genomic Identifiability. Policy Forum Science 2013;339:275-6.
51. European Society of Human Genetics. Genetic testing in asymptomatic minors: recommendations of the European Society of Human Genetics. Eur J Hum Genet 2009;17:720-1.
52. The American Society of Human Genetics Board of Directors and The American College of Medical Genetics Board of Directors. Points to consider: Ethical, legal and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet 1995;57:1233-41.
53. Wertz D, J Fanos J, Reilly P. Genetic testing for children and adolescents. Who decides? J Am Med Assoc JAMA 1994;272:875-81.
54. Lippman A. Prenatal genetic testing and screening: constructing needs and reinforcing inequities. Am J Law Med 1991;17:15-50.
55. Quinn GP, Vadaparampil ST, Bower B, et al. Decisions and ethical issues among BRCA carriers and the use of preimplantation genetic diagnosis. Minerva Med 2009;100:371-83.
56. Kapp MB. Physicians' legal duties regarding the use of genetic test to predict and diagnose Alzheimer disease. J Leg Med 2000;21:445-75. (Pubitemid 32015359)
57. Kim SY, Karlawish JH, Caine ED. Current state of reseaerch on decision-making competence of cognitively impaired elderly persons. Am J Geriatric Psychiatry 2002;10:151-5.
58. OECD Guidelines for Quality Assurance of Molecular Genetic Testing. 2007. http:// www.oecd.org/sti/biotechnologypolicies/38839788.pdf
59. Murray T. Genetic Exceptionalism and 'Future Diaries': Is Genetic Information Different from Other Medical Information? In: Rothstein M. ed. Genetic secrets: protecting privacy and confidentiality in the genetic era. New Haven: Yale University Press, 1997:60-73.